Camille Picard

Patients’ quality of life during active cancer treatment: a qualitative study

L. Verneuil, J. Sibeoni, A. Révah-Lévy, 2018, BMC Cancer.

Decisional procalcitonin thresholds are not adapted toelderly patients admitted to the emergency room

D. Borderie, Y. Claessens, C. Chenevier-Gobeaux, 2012, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

Rechallenge of immune checkpoint inhibitor after pembrolizumab-induced myasthenia gravis.

C. Lebbé, A. Carpentier, M. de Pontville, 2019, European journal of cancer.

Patients’ quality of life during active cancer treatment: a qualitative study

L. Verneuil, J. Sibeoni, G. Bousquet, 2018, BMC Cancer.

Crossing the perspectives of patients, families, and physicians on cancer treatment: A qualitative study

L. Verneuil, J. Sibeoni, G. Bousquet, 2016, Oncotarget.

Transfusion and Morbi-Mortality Factors: An Observational Descriptive Retrospective Pediatric Cohort Study

S. Albinni, G. Orliaguet, F. Cresci, 2017 .

Man against machine reloaded: performance of a market-approved convolutional neural network in classifying a broad spectrum of skin lesions in comparison with 96 dermatologists working under less artificial conditions.

R. Hofmann-Wellenhof, H. Haenssle, R. Schneiderbauer, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.